Stockholm University
Stockholm, 10691, Sweden
NCT Number: NCT05015166
The aim of this randomized, controlled study is to examine an internet delivered, self-help program for social anxiety based on psychodynamic therapy. The study will compare three conditions: the psychodynamic program with therapist support, without therapist support and a waitlist control.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stockholm, 10691, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The following self-reported diagnoses are excluded:
During 8 weeks of treatment participants are taught how emotional conflicts may underlie and perpetuate symptoms of social anxiety. They are also taught how to observe their own anxiety and emotional avoidance (i.e. defenses) and how to gradually approach previously warded off feelings. The final part of the program contains material on how one may express previously warded off emotions to improve important relationships. The treatment program consists of text, videos and a series of experiential exercises which a therapist gives feedback on.
During 8 weeks of treatment participants are taught how emotional conflicts may underlie and perpetuate symptoms of social anxiety. They are also taught how to observe their own anxiety and emotional avoidance (i.e. defenses) and how to gradually approach previously warded off feelings. The final part of the program contains material on how one may express previously warded off emotions to improve important relationships. The treatment program consists of text, videos and a series of experiential exercises.
Time frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)
The LSAS-SR features 48 items assessing social anxiety symptoms.
Time frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)
The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder.
Time frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)
The PHQ-9 features nine items for assessing depression in a clinical context and screening of depression in the general population
Time frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)
The BBQ features 12 items concerning 6 areas of life rated on importance and satisfaction.
Time frame: Baseline
The PID-5 is a self-rated measure of personality-related problems featuring 25 items.
Time frame: Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment)
Features 30 items assessing psychological strategies for handling emotional distress.
Time frame: Change from baseline, week 3 and 6, to post-treatment (8 weeks) and follow up (6, 12 and 24 months after treatment)
The SCS-SF features 12 items to record self-compassion towards yourself in difficult life situations.
Time frame: Change from baseline to post-treatment (8 week)
DMRS-SR-30 features 30 items assessing psychological factors that influence emotional distress and quality of life.
Time frame: Change from baseline, treatment week 1-8, to post-treatment (8 weeks).
RFQ features 8 items assessing the ability to understand mental states of the self and others.
Time frame: Change from baseline, and week 4, to post-treatment (8 weeks).
iiPAS is rated by a clinician and features 5 items assessing a particular patient's adherence to internet-delivered psychological interventions.
Stockholm University
Other
Acronym: STePS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06054386
Anxiety Disorders, Mental Disorders
Milwaukee, Wisconsin, United States
View Trial DetailsNCT07562633
Anxiety Disorders, Mental Disorders
Gujranwala, Punjab Province, Pakistan
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT03175068
Anxiety Disorders, Depressive Disorder
Chicago, Illinois, United States
View Trial Details